Amazon’s 14,000 Layoffs: AI Revolution or Overhiring Hangover?
Is this a bold move toward an AI-powered future, or just the latest example of Big Tech correcting its pandemic overexpansion? 🚨 What Happened Amazon confirmed it will eliminate around
Is this a bold move toward an AI-powered future, or just the latest example of Big Tech correcting its pandemic overexpansion? 🚨 What Happened Amazon confirmed it will eliminate around
Unlock ChatGPT's new powers! Control Spotify, Figma, and more—all in one chat. Streamline your life today!
How to Build for GEO — and Rank on ChatGPT Everyone spent the last decade learning how to rank on Google.
AI is changing growth hacking from a manual grind into a self-running system. Whether you’re running a startup or solo project, these five automations can help you grow faster, without adding headcount.
Every time you ask ChatGPT a question, generate an image, or use an AI-powered search, a vast network of servers springs into action. Training GPT-3 alone consumed about 1,287 megawatt-hours of electricity, roughly the yearly energy use of 120 U.S. homes.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.